Clinical Trials Sponsored by GigaGen, Inc.

Total 35749 results

GigaGen, Inc.

Terminated

Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients

COVID-19

United States
GangaGen, Inc.

Completed

Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients

Bacterial Infections | Infectious Disease

Singapore
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Chronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)

United States
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers

Healthy Volunteers

Canada
miRagen Therapeutics, Inc.

Terminated

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Belgium
GigaGen, Inc.
National Cancer Institute (NCI)

Recruiting

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Advanced or Metastatic Solid Tumor Malignancies

United States
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study

Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Testing of Respiratory Samples

Respiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditions

United States
Nivagen Pharmaceuticals Inc.

Completed

Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids

Internal Hemorrhoids

United States, India
miRagen Therapeutics, Inc.

Terminated

SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides (SOLAR)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
miRagen Therapeutics, Inc.

Completed

Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids

Keloid

United States
miRagen Therapeutics, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MRG-110 Following Intradermal Injection in Healthy Volunteers

Healthy Volunteer

United States
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay

Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Completed

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the Artus® CMV PCR Test (CMV)

Cytomegalovirus Infections

United States
QIAGEN Gaithersburg, Inc

Terminated

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People (QFM)

HIV Positive

United States
QIAGEN Gaithersburg, Inc

Recruiting

Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

SARS-CoV-2 Acute Respiratory Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Recruiting

QIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study

Blood Disease

United Kingdom
QIAGEN Gaithersburg, Inc

Active, not recruiting

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

Meningitis/Encephalitis

United Kingdom
QIAGEN Gaithersburg, Inc

Withdrawn

QuantiFERON Access Clinical Performance Study Protocol

Tuberculosis (TB)
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the AmniSure ROM Test

Rupture of Fetal Membranes

United States
QIAGEN Gaithersburg, Inc

Terminated

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Cell-mediated Immune Response

United States
QIAGEN Gaithersburg, Inc

Completed

Collection and Extraction of Respiratory Specimens

Influenza

United States
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

Non Small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Recruiting

Therascreen® KRAS RGQ PCR Kit

Colo-rectal Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit

Non-small Cell Lung Cancer

United Kingdom
QIAGEN Gaithersburg, Inc
Amgen

Active, not recruiting

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Colorectal Cancer | Non-Small Cell Lung Cancer

United Kingdom
Icagen

Completed

Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

Exercise Induced Asthma

United States
Icagen

Completed

Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects

Atopic Asthma

United Kingdom
Barretos Cancer Hospital
QIAGEN Gaithersburg, Inc

Completed

Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas (careHPV)

Human Papilloma Virus Infection | Prevention | Cervical Cancer Squamous Cell | Human Papilloma Virus-Related Carcinoma

Brazil
Laser Surgery Care
QIAGEN Gaithersburg, Inc

Completed

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

Anal Cancer | Anal Canal HPV Infection Diagnosis | Anal Dysplasia Diagnosis

United States
Icagen

Completed

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

Sickle Cell Disease | Sickle Cell Anemia

United States
Rennes University Hospital
QIAGEN Gaithersburg, Inc

Completed

cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project (KitMel)

Melanoma

France
Karsten Königstein
University of Basel; QIAGEN Gaithersburg, Inc

Completed

VascuFit: Exercise and Vascular Aging (VascuFit)

Aerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)

Switzerland
University Hospital, Geneva
QIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia AC

Completed

Prediction of Spontaneous Onset of Labor at Term (PREDICT)

Labor Onset | Labor, Induced | Labor, Obstetric | Predictive Model

Switzerland
Assistance Publique - Hôpitaux de Paris
QIAGEN Gaithersburg, Inc

Active, not recruiting

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room (PROMCAP)

Community-acquired Pneumonia

France
Maimónides Biomedical Research Institute of Córdoba
QIAGEN Gaithersburg, Inc

Unknown

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients (CYTHEMAT)

Cytomegalovirus Infection | HSCT

Spain
Maria Gyhagen

Completed

Development and Validation of a Logistic Regression Algorithm to Predict the Risk of Obstetric Anal Sphincter Injury.

Sphincter (Anal); Perineal Rupture, Obstetric

Sweden
Icagen
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Terminated

A Stratified Sickle Event Randomized Trial (ASSERT) (ASSERT)

Sickle Cell Disease

United States, France, United Kingdom, Brazil, Jamaica, Trinidad and Tobago
Icagen
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Terminated

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

Sickle Cell Disease | Sickle Cell Anemia

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Sociedad Española de Medicina Nuclear e Imagen...

Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177 (SEPTRALU)

Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Endocrine System Diseases | Stomach Neoplasms | Gastrointestinal Neoplasms | Digestive System Neoplasms | Neoplasms, Germ Cell and Embryonal | Endocrine Gland Neoplasms | Neuroectodermal Tumors | Neoplasms, Nerve Tissue | Intestinal Diseases and other conditions

Spain
University of Ulm
Medical University of Graz; Technical University of Munich; QIAGEN Gaithersburg... and other collaborators

Completed

GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps (GENESIS)

Colonic Polyps

Germany, Austria
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
Concordia Dent Srl
Carol Davila University of Medicine and Pharmacy; MEGAGEN DENTAL IMPLANT ROMANIA

Completed

Accuracy of Computer Guided Implant Surgery (STIMPLANTSRG)

Jaw, Edentulous

Romania

Clinical Trials Sponsored by GigaGen, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations